Taussig HB. A study of the German outbreak of phocomelia

[1] Taussig HB. A study of the German outbreak of phocomelia. The thalidomide syndrome. JAMA. 1962 Jun 30;180:1106-14.PMID: 13919869
[2] Yonkman FF.Thalidomide and Related Compounds. JAMA.1962;181(7):654.
[3]Thalidomide’s Secret Past: The Link with Nazi Germany. Onco’Zine – The International Oncology Network, December 4, 2013
[4] Kessel, N. ?Doriden von Ciba?: sleeping pills, pharmaceutical marketing, and Thalidomide, 1955?1963. History and Technology: An International Journal 29; 2. 2013. DOI:10.1080/07341512.2013.828509
[5] Controversy: The involvement of Ciba AG in the development of Thalidomide. Onco’Zine – The International Cancer Network
[6] Stephens T , Brynner R . Dark Remedy: The Impact of Thalidomide and Its Revival as a Vital Medicine . Cambrigde, Mass: Basic Books/Perseus Publishing; 2001. ISBN-10: 0738205907
[7] Somers GF. Pharmacological properties of thalidomide (alpha-phthalimido glutarimide), a new sedative hypnotic drug. Br J Pharmacol Chemother. 1960 Mar;15:111-6.SOMERS GF.
[8] Lenz W.A short history of thalidomide embryopathy. Teratology. 1988 Sep;38(3):203-15.
[9] Linda Bren. Frances Oldham Kelsey: FDA Medical Reviewer Leaves Her Mark on History. FDA Consumer 2001; 35 (2) March-April
[10] A. Leslie Florence Is Thalidomide to Blame? Br Med J 1960;2:1954.1
[11] Wiedemann, H.R. Himweis auf eine derzeitige, H?ufung hypo-und aplastischer Fehlbildunger der Gliedmassen (Indications of a current increase of hypoplastic and aplastic deformities of the extremities). Med Welt. 1961 Sep 16;37:1863-6.
[12] McBride WG. Thalidomide and congenital malformations. Lancet 1961; 2: 1358
[13] Lenz W. Thalidomide embryopathy in Germany, 1959-1961 Prog Clin Biol Res. 1985;163C:77-83.
[14] Papers of William McBride, ca. 1953-1996, National Library of Australia, Last accessed November 28 2013 [Catalogue]
[15] T , Bjorkman S , Hoglund P . Clinical pharmacology of thalidomide . Eur J Clin Pharmacol . 2001;57:365?376
[16] Ridings JE.The thalidomide disaster, lessons from the past.Methods Mol Biol. 2013;947:575-86. doi: 10.1007/978-1-62703-131-8_36.
[17] Smithells D. Was the thalidomide tragedy preventable? Lancet. 1998 May 23;351(9115):1591.
[18] Sheskin J. Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 1965;40:303-6.
[19] Zwingenberger K, Wnend S. Immunomodulation by thalidomide: systemic review of the literature and of unpublished observations. J Inflamm 1995; 46: 177?221.
[20] Moreira AL, Sampaio EP, Zmuidzinas A. Thalidomide exerts its inhibitory action on tumor necrosis factor by enhancing mRNA degradation. J Exp Med 1993; 177: 1675?1680.
[21] Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, et al Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med. 1999 Nov 18;341(21):1565-71
[22] Stephens TD, Bunde CJ, Fillmore BJ Mechanism of action in thalidomide teratogenesis. Biochem Pharmacol. 2000 Jun 15;59(12):1489-99.
[23] Paravar T, Lee DJ. Thalidomide: mechanisms of action. Int Rev Immunol. 2008;27(3):111-35. doi: 10.1080/08830180801911339.
[24] Lu G, Middleton RE, Sun H, Naniong M, Ott CJ, Mitsiades CS, Wong KK, Bradner JE, Kaelin WG Jr. The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins. Science. 2013 Nov 29.